NEW YORK, NY / ACCESSWIRE / December 18, 2022 / WHY: Rosen Law Firm, a global investor rights law firm, announces that it will file a class action lawsuit on behalf of purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) securities between December 6, 2021 and September 22, 2022, both dates including ( the “class period”). If you want to appear as lead plaintiff, you must call the court by February 2, 2023 at the latest.
SO WHAT: If you purchased Spectrum Securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To participate in the Spectrum fundraiser, go to https://rosenlegal.com/submit-form/?case_id=9455 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by February 2, 2023 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.
WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever securities class-action settlement against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. 2020 Foundation…
source_link https://www.digitaljournal.com/pr/rosen-a-longstanding-law-firm-encourages-spectrum-pharmaceuticals-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-sppi